Pyrrolnitrin, a new antifungal antibiotic. Microbiological and toxicological observations.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000187:drug effects*; D003883:Arthrodermataceae / Q000187:drug effects*; D001412:Bacillus subtilis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000151:congenital; D003470:Culture Media / Q000187:drug effects; D006118:Griseofulvin / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D009161:Mycobacterium / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011758:Pyrroles / Q000494:pharmacology*; D012505:Sarcina / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000151:congenital / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D003470:Culture Media; D011758:Pyrroles; D006118:Griseofulvin